Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
Resistentie-analyse HCV na ledipasvir/sofosbuvir
sep 2017 | Hepatitis
jun 2024 | Niertransplantatie, Stamceltransplantatie, Virale infecties